Agios Pharmaceuticals Appoints William Kaelin Jr., M.D. to Scientific Advisory Board

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the appointment of William Kaelin Jr., M.D., to its scientific advisory board. Dr. Kaelin currently serves as a Professor of Medicine at Harvard Medical School. Dr. Kaelin’s laboratory focuses on tumor suppressor genes and the normal functions of the proteins they encode.

Back to news